- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04839952
Pilot Evaluation of a Healthy Lifestyle Intervention for Adolescent and Young Adult Survivors of Pediatric Cancer
August 31, 2023 updated by: Johns Hopkins All Children's Hospital
This is a feasibility and acceptability trial to test a newly developed healthy lifestyle intervention for adolescent and young adult survivors of pediatric cancer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Saint Petersburg, Florida, United States, 33701
- Johns Hopkins All Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants will be adolescents and young adults (15-25 years of age) who have completed cancer treatment at Johns Hopkins All Children's Hospital any time in the last five years. This age range was chosen because it corresponds to the recommended age range for cancer-related adolescents and young adult studies38.
- If the adolescent or young adult patient lives with a parent, other adult family member, or adult romantic/platonic partner, that person will also be invited to participate in the intervention as a support to the patient.
- If the adolescent or young adult patient lives with a parent or romantic partner, the parent or romantic partner will also be invited to participate in the intervention as a support to the patient. A parent or romantic partner is eligible to participate if the patient lives with them at least 50% of the time. The parent or romantic partner will not receive separate financial compensation for participation. Herein, we use the word "parent" only because we expect the vast majority of patients will live with a parent instead of a romantic partner. Patients who do not live with a parent or romantic partner will participate alone.
- The patient's cancer treatment must have included chemotherapy and/or radiation.
- If a patient's cancer relapses during the study period, the patient's oncologist must agree to the patient continuing in this intervention.
Exclusion Criteria:
- Potential participants who appear to have cognitive, motor, or language delays, as observed by research personnel or documented in the medical record, will be excluded from this study if delays preclude informed consent and/or study completion. Participants may request that research personnel read all assessment, education, and intervention materials aloud in a structured interview format, in which case participants could respond to items verbally and/or by pointing to visual aids. Because of this option, participants' ability to read and write are not requirements for participation.
- Because the motivational interviewing component of the intervention is language-dependent and requires significant time and training for certification in another language, non-English speaking patients will only be included in this study if the psychology postdoctoral fellow hired in this study is a native Spanish speaker and can demonstrate motivational interviewing proficiency in Spanish.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy Lifestyles Intervention Arm
Participants will receive the healthy lifestyles intervention.
|
12 telehealth sessions.
The first 5 visits include psycho/medical education plus a motivational interviewing component.
The second 7 sessions include psycho/medical education plus a problem solving training component.
|
|
Active Comparator: Education-Only Control Arm
Participants will receive the education-only intervention.
|
This control condition includes meeting with a clinician for one telehealth visit to review nutrition and physical activity recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Nutrition knowledge as assessed by the General Nutrition Knowledge Questionnaire
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Knowledge of nutrition recommendations, as evidenced by scores on the General Nutrition Knowledge Questionnaire - Revised (higher scores indicate greater knowledge).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Physical activity knowledge as assessed by the Knowledge of American Heart Association Physical Activity Recommendations Questionnaire
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Knowledge of physical activity recommendations, as evidenced by scores on the Knowledge of American Heart Association Physical Activity Recommendations Questionnaire (higher scores indicate greater knowledge).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Physical activity as assessed by Fitbit data
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Physical activity total weekly minutes, as evidenced by weekly Fitbit data (activity measured in minutes).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Nutrition as assessed by the Rapid Eating Assessment for Patients score
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Adherence to United States Department of Agriculture recommendations, as evidenced by the Rapid Eating Assessment for Patients (higher scores indicate better adherence to recommendations).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Intervention feasibility as assessed by the fidelity rating
Time Frame: Immediately following intervention
|
Feasibility of conducting the intervention with high clinician fidelity, as evidenced by fidelity ratings for each session (fidelity represented as a percentage based on the extent to which the clinician covered all planned information for each session).
Average intervention fidelity ratings should meet or exceed 80% fidelity.
|
Immediately following intervention
|
|
Intervention acceptability as assessed by the Abbreviated Acceptability Rating Profile
Time Frame: Immediately following intervention
|
Patient and caregiver acceptability of the newly developed intervention, as evidenced by the Abbreviated Acceptability Rating Profile (higher scores indicate greater acceptability, with scores equal to or greater than 30 indicating good acceptability per published standards).
|
Immediately following intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Healthy lifestyle self-efficacy as assessed by the Weight Efficacy Lifestyle Questionnaire Short Form
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Self-efficacy managing weight, as evidenced on scores on the Weight Efficacy Lifestyle Questionnaire Short Form (greater scores indicate greater self-efficacy).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Healthy lifestyle self-efficacy as assessed by the Healthy Promoting Lifestyle Profile II
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Self-efficacy maintaining healthy lifestyle behaviors, as evidenced by scores on the Healthy Promoting Lifestyle Profile II ((greater scores indicate greater self-efficacy).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Body satisfaction as assessed by the Body Esteem Scale for Adults and Adolescents
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Body satisfaction, as evidenced by scores on the Body Esteem Scale for Adults and Adolescents (higher scores indicate greater body satisfaction).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Depression as assessed by the PROMIS Depressive Symptoms-Short Form
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Depressive symptoms, as evidenced by scores on the PROMIS Pediatric Depressive Symptoms-Short Form or PROMIS Adult Depressive Symptoms-Short Form (greater scores indicate greater depressive symptoms).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Anxiety as assessed by the PROMIS Anxiety Symptoms- Short Form
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
PROMIS Pediatric Anxiety Symptoms- Short Form or PROMIS Adult Anxiety Symptoms Short Form (greater scores indicate greater anxiety symptoms).
|
Pre-intervention and 2 months after the intervention concludes
|
|
Change in Self-esteem as assessed by the Rosenberg Self Esteem Scale
Time Frame: Pre-intervention and 2 months after the intervention concludes
|
Self-esteem, as evidenced by scores on the Rosenberg Self Esteem Scale (greater scores indicate greater self-esteem).
|
Pre-intervention and 2 months after the intervention concludes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Melissa A. Faith, Ph.D., ABPP, Johns Hopkins All Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 11, 2020
Primary Completion (Actual)
August 31, 2023
Study Completion (Actual)
August 31, 2023
Study Registration Dates
First Submitted
April 8, 2021
First Submitted That Met QC Criteria
April 8, 2021
First Posted (Actual)
April 9, 2021
Study Record Updates
Last Update Posted (Actual)
September 5, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00238848
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Rigshospitalet, DenmarkDanish Cancer Society; Danish Child Cancer FoundationNot yet recruitingPediatric Cancer | Pediatric Cancer PatientsDenmark
-
Associazione Italiana Ematologia Oncologia PediatricaRecruitingRehabilitation | Pediatric Cancer | Physical Therapy | Pediatric Oncology | Pediatric Cancer Patients | Motor OutcomesItaly
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationCompletedCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Eskisehir Osmangazi UniversityNot yet recruitingPediatric Cancer | Resilience, Psychological | Mobile Application | Coping | Adolescent Cancer | Pediatric NursingTurkey (Türkiye)
-
University of Witten/HerdeckeHeidehof Foundation Stuttgart; Community Hospital Herdecke; Nordoff/Robbins Music... and other collaboratorsRecruiting
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
Children's Hospital Los AngelesRecruiting
-
University of California, San FranciscoWithdrawnPediatric CancerUnited States
Clinical Trials on Healthy Lifestyles
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Brigham and Women's HospitalJohns Hopkins University; Case Western Reserve University; Partners HealthCare; VA Boston Healthcare SystemCompletedCoronary Artery Disease | Cardiovascular Disease | Obstructive Sleep ApneaUnited States
-
Bronx-Lebanon Hospital Center Health Care SystemUnitedHealthcare FoundationUnknownChildhood ObesityUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedDevelopmental Disabilities | Mental Retardation | Intellectual DisabilitiesUnited States
-
Guangzhou Women and Children's Medical CenterCompleted
-
University of Kansas Medical CenterNational Institute of Nursing Research (NINR)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); University of North Carolina, CharlotteCompletedColorectal NeoplasmsUnited States
-
Duke UniversityUniversity of North Carolina, Chapel HillCompletedChildhood ObesityUnited States
-
University of PittsburghNational Institute of Nursing Research (NINR)CompletedLiving DonationUnited States
-
Children's Hospital of Eastern OntarioChildren's Hospital Academic Medical Organization (CHAMO)Recruiting